Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CNTG

Centogene NV (CNTG)

Centogene NV
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CNTG
일자시간출처헤드라인심볼기업
2024/06/0105:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/06/0105:30GlobeNewswire Inc.CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General MeetingNASDAQ:CNTGCentogene NV
2024/05/2920:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/05/1720:20Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NASDAQ:CNTGCentogene NV
2024/05/1606:17GlobeNewswire Inc.CENTOGENE Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CNTGCentogene NV
2024/05/1606:12Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:CNTGCentogene NV
2024/05/1606:10GlobeNewswire Inc.CENTOGENE Secures Approx. $20 Million to Strengthen Cash PositionNASDAQ:CNTGCentogene NV
2024/05/1606:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/05/1605:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/05/1421:30GlobeNewswire Inc.CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher DiseaseNASDAQ:CNTGCentogene NV
2024/05/1421:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/05/1019:30GlobeNewswire Inc.CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse PatientsNASDAQ:CNTGCentogene NV
2024/05/1019:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/04/0305:30GlobeNewswire Inc.CENTOGENE Receives Nasdaq Non-Compliance NoticeNASDAQ:CNTGCentogene NV
2024/03/1919:30GlobeNewswire Inc.CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage DisordersNASDAQ:CNTGCentogene NV
2024/03/0107:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/03/0107:00GlobeNewswire Inc.CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα DeficiencyNASDAQ:CNTGCentogene NV
2024/02/2820:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/02/2820:30GlobeNewswire Inc.CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a HearingNASDAQ:CNTGCentogene NV
2024/02/2820:30GlobeNewswire Inc.CENTOGENE Explores Strategic AlternativesNASDAQ:CNTGCentogene NV
2024/02/2820:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/01/2520:30GlobeNewswire Inc.CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationNASDAQ:CNTGCentogene NV
2024/01/2520:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/01/2420:30GlobeNewswire Inc.CENTOGENE Receives French Research Tax Credit AccreditationNASDAQ:CNTGCentogene NV
2024/01/2420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/01/2320:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/01/2320:30GlobeNewswire Inc.CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using MultiomicsNASDAQ:CNTGCentogene NV
2024/01/1821:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
2024/01/1820:30GlobeNewswire Inc.CENTOGENE Announces Preliminary Full Year 2023 RevenueNASDAQ:CNTGCentogene NV
2023/12/1921:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
 검색 관련기사 보기:NASDAQ:CNTG